165 KRW
−3.98 B KRW
42.65 B KRW
40.99 M
About KOMIPHARM INTERNATIONAL CO., LTD.
Sector
Industry
Headquarters
Siheung-si
Website
Founded
1972
ISIN
KR7041960006
FIGI
BBG000BMB381
Komipharm International Co., Ltd. engages in the development and manufacturing of natural food additives, veterinary vaccines and pharmaceuticals. It operates through Animal Health and Pharmaceuticals divisions. The Animal Health division manufactures veterinary products such as vaccines, antibiotics, antibacterial, nutrition, metabolic, immune boosters, digestive enzymes, expectorant, hormone, skin disease, anesthetic, antipyretic-analgesics and organic acid for being used to livestock, aqua and pet animals. The Pharmaceutical division develops pharmaceutical products such as anticancer drug and cancer pain-relieving agent under KOMINOX and PANAPHIX projects. The company was founded on September 21, 1972 and is headquartered in Siheung-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 041960 is 3,790 KRW — it has decreased by −0.52% in the past 24 hours. Watch KOMIPHARM INTERNATIONAL CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KOMIPHARM INTERNATIONAL CO., LTD. stocks are traded under the ticker 041960.
041960 stock has fallen by −2.07% compared to the previous week, the month change is a −4.65% fall, over the last year KOMIPHARM INTERNATIONAL CO., LTD. has showed a −6.54% decrease.
041960 reached its all-time high on Sep 9, 2016 with the price of 47,510 KRW, and its all-time low was 250 KRW and was reached on Jun 28, 2004. View more price dynamics on 041960 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
041960 stock is 1.20% volatile and has beta coefficient of 0.34. Track KOMIPHARM INTERNATIONAL CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is KOMIPHARM INTERNATIONAL CO., LTD. there?
Today KOMIPHARM INTERNATIONAL CO., LTD. has the market capitalization of 263.97 B, it has decreased by −2.43% over the last week.
Yes, you can track KOMIPHARM INTERNATIONAL CO., LTD. financials in yearly and quarterly reports right on TradingView.
041960 net income for the last quarter is 6.49 B KRW, while the quarter before that showed 5.09 B KRW of net income which accounts for 27.52% change. Track more KOMIPHARM INTERNATIONAL CO., LTD. financial stats to get the full picture.
No, 041960 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 153.00 employees. See our rating of the largest employees — is KOMIPHARM INTERNATIONAL CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KOMIPHARM INTERNATIONAL CO., LTD. EBITDA is 5.92 B KRW, and current EBITDA margin is −6.43%. See more stats in KOMIPHARM INTERNATIONAL CO., LTD. financial statements.
Like other stocks, 041960 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KOMIPHARM INTERNATIONAL CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KOMIPHARM INTERNATIONAL CO., LTD. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KOMIPHARM INTERNATIONAL CO., LTD. stock shows the sell signal. See more of KOMIPHARM INTERNATIONAL CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.